企業プロフィール
Pfizer, Inc. 株価・ニュース・カタリスト
- ティッカー:
- PFE
- 取引所:
- NYSE
- セクター:
- Biopharma, Oncology, Vaccines
- 所在地:
- United States
株価パフォーマンス
26.87 USD (+0.30%)
終値
最終更新: 2026年8月17日
146B USD
時価総額
株価変動の要因
As of Aug 17, 2026, PFE closed up 0.30% at $26.87. No new same-company headline was identified in the current news window.
企業概要
事業概要
Pfizer is a global pharmaceutical company spanning vaccines, oncology, inflammation, rare disease, and hospital products. The company’s narrative is now centered on post-COVID portfolio renewal and pipeline execution.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Pfizer has one of the broadest global commercial footprints in healthcare. It sits in large-cap pharma with strong international reach.
ビジネスモデルの特徴
Pfizer depends on product sales, pipeline replacement, lifecycle management, and strategic capital allocation. Investors focus on earnings quality, launch timing, and how effectively the company can rebuild growth after major patent and demand transitions.
バイオ業界での位置付け
Pfizer is a mature large-cap pharma name with enough pipeline and vaccine exposure to retain catalyst sensitivity. It is not a binary biotech stock, but major approvals and portfolio shifts still matter.
今後のカタリスト
- Pfizer’s near-term catalysts are likely to be post-Seagen oncology execution, selected late-stage pipeline updates, and evidence that the company’s post-COVID revenue mix is getting more stable. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
最近のニュース
- 01
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。